1d
ABP News on MSNUS Tariffs Pose Minimal Threat To Indian Pharma, Says Citi; Details HereCurrently, India imposes a 10 per cent tariff on pharmaceutical imports from the US, while the US does not levy any tariff on ...
Citi's analysis indicates that companies with lower exposure to US generics, including Torrent Pharma, Sun Pharma, and Divi's ...
If the average tariff rate passes 20%, that could push the US into stagflation territory and give the economy a growth shock, ...
Explore Citi CD rates. We share current Citi CD rates, explain their features, and can help you decide if they align with ...
Imposing tariffs could lead to drug shortages in the US if Indian suppliers were to exit the market. Citi's report suggests ...
The Mets superstar spoke to SI about the return of Verdansk in 'Call of Duty: Warzone' and why he wanted to stay in NYC after ...
U.S. District Judge Tanya Chutkan on Wednesday questioned a Department of Justice attorney over whether the Environmental ...
SINGAPORE] The next generation of ultra-high-net-worth (UHNW) individuals will likely boost the uptake of donor-advised funds ...
Jefferies maintains that companies with mixed revenue streams, such as specialty pharma, biosimilars, and inhalers, may face ...
The survey, which captured responses from over 2,000 U.S. taxpayers, indicates that online filing remains the preferred ...
Citi analyst Michael Rollins maintained a Hold rating on T Mobile US (TMUS – Research Report) yesterday. The company’s shares closed yesterday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results